First joint ESC/EAS guidelines for the management of dyslipidaemias
Tuesday, June 28, 2011 - 06:50
in Health & Medicine
Cardiovascular disease (CVD), driven by the global pandemics of obesity and diabetes, poses a daunting challenge to clinicians in the 21st century. Despite progress, there is still much to be done to improve the control of dyslipidaemia, a key risk factor. In Europe, as many as one-half of patients are inadequately treated.1,2 The first European guidelines specifically focused on managing dyslipidaemias offer new hope.3,4 Experts from the European Atherosclerosis Society (EAS) and the European Society of Cardiology (ESC) worked together to develop these guidelines. The aim was to keep pace with emerging data and provide up to date treatment advice for a wide range of dyslipidaemias, including diabetes and metabolic syndrome.